Posted on Leave a comment

DNA Testing Market is Expected to Grow at the CAGR of 9.9% During 2015-2022: Brisk Insights has announced the addition of “Global DNA Testing Market Size, Share, Trends, Growth, Analysis And Forecast To 2022” Market Research Report to their Database.

According to a recently published report, the DNA Testing Market is expected to grow at the CAGR of 9.9% during 2015-2022. The segmentation of GLOBAL DNA TESTING MARKET is based on product type, technology, application, end user and geography. The report on GLOBAL DNA TESTING MARKET Forecast, 2015-2022 (by product type, technology, application, end user and geography) provides detailed overview and predictive analysis of the market.

Growing infectious and chronic diseases is the key driver to DNA testing market. The patient population is increasing rapidly due to growing infection caused by fungi, bacteria viruses; the need to detect the disease earlier DNA testing is being used. Increasing point of care center is another factor influencing the market largely. Point of care centers provides diagnosis and testing convenient to the patient residence and facilitates immediate results.

Full report available GLOBAL DNA TESTING MARKET Forecast, 2015-2022 (by application, product type and geography) report at

Scope of the report

1. GLOBAL DNA TESTING MARKET by product type, 2012 – 2022 ($ billion)
1.1. Instruments
1.2. Reagents
1.3. Software & Services

2. GLOBAL DNA TESTING MARKET by technology, 2012 – 2022 ($ billion)
2.1. PCR
2.2. Microarrays
2.3. In situ hybridization
2.4. Sequencing Technology
2.5. Mass Spectrometry

3. GLOBAL DNA TESTING MARKET by Application, 2012 – 2022 ($ billion)
3.1. Oncology
3.1.1. Prostate Cancer
3.1.2. Breast Cancer
3.1.3. Colorectal Cancer
3.2. Infectious disease testing
3.2.1. Hepatitis B Virus (HBV)
3.2.2. Hepatitis C Virus (HCV)
3.2.3. Human Immunodeficiency Virus (HIV)
3.2.4. Tuberculosis (TB)
3.2.5. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG
3.2.6. Human Papillomavirus (HPV)
3.2.7. Methicillin-Resistant Staphylococcus Aureus (MRSA)
3.3 Myogenic disorder diagnosis
3.4 Clinical diagnosis confirmation
3.5 Prenatal diagnosis
3.6 Pre-implantation diagnosis

4. GLOBAL DNA TESTING MARKET by end user, 2012 – 2022 ($ billion)
4.1. Point of Care
4.2. Central Laboratories/Diagnostic Centers
4.3. Self Testing/OTC

5. GLOBAL DNA TESTING MARKET by, regional outlook, 2012-2022(in $billion)
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Row

6. Company profiles
6.1. Novartis
6.2. Johnson and Johnson
6.3. Bio-Rad Laboratories
6.4. Thermo Fisher Scientific
6.5. Illumina, Inc.
6.6. Gen-probe Inc. (Hologic)
6.7. Cephide Inc.
6.8. Abbott Laboratories
6.9. Roche Diagnostics
6.10. Bayer Diagnostic
6.11. Sysmex
6.12. Agilent Technologies Inc.
6.13. GE Healthcare,
6.14. Transgenomic Inc
6.15. Qiagen

Latest Report:

Agriculture Biotechnology Market

About Us:

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to  aid businesses identify market opportunities optimize strategies. Our team of 200 analysts provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions. Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

Web: Brisk Insights


Media Contact
Company Name: Brisk Insights
Contact Person: Jennifer Smith, Manager – Sales
Phone: +448081890034 (UK)
Address:Office 1094 109 Vernon House Friar Lane
City: Nottingham
Country: United Kingdom